Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 24,191Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Pfizer Inc

02 18Pierre Fabre

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2018-06-27

Application Number : 210496

Regulatory Info : DISCN

Registration Country : USA

blank

02

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE;ORAL

Dosage Strength : 75MG

Packaging :

Approval Date : 2018-06-27

Application Number : 210496

Regulatory Info : RX

Registration Country : USA

blank

03

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

ENCORAFENIB

Brand Name : BRAFTOVI

Dosage Form : CAPSULE

Dosage Strength : 75MG

Packaging :

Approval Date :

Application Number : 2513099

Regulatory Info : Prescription

Registration Country : Canada

blank

04

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 01/11/2019

Application Number : 66795

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 75mg

Packaging :

Approval Date : 01/11/2019

Application Number : 66795

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

07

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

08

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

09

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 75mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

10

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 50MG

Packaging :

Approval Date : 04-10-2018

Application Number : 1181314001

Regulatory Info : Authorized

Registration Country : Spain

blank

11

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsule

Dosage Strength : 75MG

Packaging :

Approval Date : 04-10-2018

Application Number : 1181314002

Regulatory Info : Authorized

Registration Country : Spain

blank

12

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsules

Dosage Strength : 50mg

Packaging :

Approval Date : 20-09-2018

Application Number : 28105997517

Regulatory Info : Prescription

Registration Country : Denmark

blank

13

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Hard Capsules

Dosage Strength : 75mg

Packaging :

Approval Date : 20-09-2018

Application Number : 28105997617

Regulatory Info : Prescription

Registration Country : Denmark

blank

14

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 50mg

Packaging :

Approval Date : 20-09-2018

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

15

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form : Capsule

Dosage Strength : 75mg

Packaging :

Approval Date : 20-09-2018

Application Number : 2.02E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

16

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

17

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

18

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

BPI West
Not Confirmed
arrow
arrow
BPI West
Not Confirmed

Encorafenib

Brand Name : Braftovi

Dosage Form :

Dosage Strength :

Packaging : 42

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank